Adenoviral-vector-mediated gene transfer to dendritic cells

Area of Science:

• Immunology
• Cell Biology
• Genetic Engineering

Background:

• Dendritic cells (DC) are potent antigen-presenting cells crucial for initiating T-cell-dependent immune responses.
• Harnessing DC potential involves transferring antigens for effective, antigen-specific immune responses.
• Antigen transfer methods include intact proteins, peptides, or gene transfer via DNA/RNA.

Purpose of the Study:

• To explore the advantages of genetically modifying DC with antigen-coding genes over peptide pulsing.
• To investigate the use of recombinant adenovirus (Ad) vectors for gene transfer into DC.
• To demonstrate the efficacy of Ad-vector-modified DC in suppressing tumor cell growth.

Main Methods:

• Utilizing recombinant adenovirus (Ad) vectors for gene transfer into murine and human dendritic cells (DC).
• Genetically modifying DC with genes encoding specific antigens and immune-response mediators.
• Applying Ad-vector-modified DC to a model of antigen-expressing tumor cells.

Main Results:

• Genetically modified DC can present novel epitopes and generate MHC class I-restricted cytotoxic T lymphocytes (CTL).
• Endogenous processing of gene products in DC leads to robust cell-mediated immune responses.
• Ad-vector-modified DC demonstrated suppression of tumor cell growth in experimental models.

Conclusions:

• Genetic modification of DC with Ad vectors offers advantages for antigen presentation and immune stimulation.
• This technology enables endogenous antigen processing, enhancing CTL generation.
• Ad-vector-modified DC represent a promising strategy for cancer immunotherapy, as exemplified by tumor growth suppression.